Showing results 21 to 40 of 241
  Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact ».DELANAYE, Pierre  ; CARLISI, Ignazia ; ROUSSELLE, Olivier et alPoster (2012) Detailed reference viewed: 14 (3 ULg)Detection of decreased glomerular filtration rate in intensive care units: interest of cystatin CDELANAYE, Pierre ; CAVALIER, Etienne ; et alPoster (2012) Detailed reference viewed: 15 (7 ULg) Two novel equations to estimate kidney function in persons aged 70 years or older; ; DELANAYE, Pierre et alin Annals of Internal Medicine (2012), 157(7), 471-481 Le médicament du mois : Fébuxostat (Adenuric®)DELANAYE, Pierre ; BOUQUEGNEAU, Antoine ; DUBOIS, Bernard et alin Revue Médicale de Liège (2012), 67(4), 202-209 Detailed reference viewed: 17 (0 ULg)Compliance of the hemodialysis patient to the native vitamin D therapyDELANAYE, Pierre ; DUBOIS, Bernard ; KRZESINSKI, Jean-Marie et alPoster (2012) Detailed reference viewed: 23 (2 ULg)Adhésion thérapeutique du patient hémodialyséDELANAYE, Pierre ; CAVALIER, Etienne ; DUBOIS, Bernard et alPoster (2012) Detailed reference viewed: 14 (2 ULg)Creatinine: Production, Physiology and Diagnostic Use in Kidney DiseasesDELANAYE, Pierre ; ; in Perkins (Ed.) Creatinine: Production, Diagnostic Uses and role in Renal Disease (2012) Detailed reference viewed: 8 (0 ULg)How measuring glomerular filtration rate? Comparison of reference methodsDELANAYE, Pierre in Sahay, Manisha (Ed.) Basic Nephrology and Acute Kidney Injury (2012) Detailed reference viewed: 10 (0 ULg)Nephrology and Clinical Chemistry: the essential linkDELANAYE, Pierre Book published by Bentham (2012) Detailed reference viewed: 11 (0 ULg) Cystatin C in HIV-infected patients: promising but not yet ready for prime time.; ; DELANAYE, Pierre in Nephrology Dialysis Transplantation (2012), 27(4), 1305-1313 Detailed reference viewed: 9 (0 ULg)Anorexia Nervosa and the KidneyBOUQUEGNEAU, Antoine ; DUBOIS, Bernard ; Krzesinski, Jean-Marie et alin American Journal of Kidney Diseases (2012), 60(2), 299-307 Anorexia nervosa is a common psychiatric disorder that disproportionately affects adolescents and young adults and is associated with high rates of morbidity and mortality. Anorexia nervosa can affect the ... [more ▼] Anorexia nervosa is a common psychiatric disorder that disproportionately affects adolescents and young adults and is associated with high rates of morbidity and mortality. Anorexia nervosa can affect the kidney in numerous ways, including increased rates of acute kidney injury and chronic kidney disease, electrolyte abnormalities, and nephrolithiasis. Additionally, the diagnosis and treatment of anorexia nervosa–associated kidney diseases are challenging, reflecting complications such as refeeding syndrome, as well as the limitations of serum creatinine level in this population to estimate kidney function and the psychosocial challenges inherent with treating systemic manifestations of psychiatric conditions. In this review, we discuss kidney diseases and kidney-associated conditions that occur in individuals with anorexia nervosa, summarizing many of the challenges in treating patients with this disease [less ▲] Detailed reference viewed: 25 (10 ULg)L'estimation du débit de filtration glomérulaire en 2012: quelle valeur ajoutée pour la nouvelle équation CKD-EPIDELANAYE, Pierre ; ; et alin Néphrologie & Thérapeutique (2012), 8 Mesurer ou estimer le debit de filtration glomerulaire (DFG) reste l’un des meilleurs moyens d’apprehender la fonction glomerulaire du rein. En 2009, l’equation Chronic Kidney Disease Epidemiology (CKD ... [more ▼] Mesurer ou estimer le debit de filtration glomerulaire (DFG) reste l’un des meilleurs moyens d’apprehender la fonction glomerulaire du rein. En 2009, l’equation Chronic Kidney Disease Epidemiology (CKD-EPI) a ete proposee en lieu et place de l’equation Modification of Diet in Renal Disease (MDRD) pour estimer le DFG. Cette nouvelle equation fait partie desormais des toutes dernieres recommandations de la Haute Autorite de sante (HAS). Par rapport a MDRD, la formule CKD-EPI est sensee moins sous-estimer le DFG mesure, principalement dans les valeurs les plus hautes de DFG. Dans cette revue critique de la litterature, nous presenterons et discuterons les performances de cette nouvelle equation. Sur base des articles publies entre 2009 et 2012, nous en soulignerons les avantages, notamment en terme d’estimation de la prevalence de la maladie renale chronique (MRC), mais aussi les faiblesses, principalement dans certaines populations specifiques. En effet, toutes ces equations reposant sur la mesure de la creatinine serique restent des estimations et le nephrologue doit donc garder son sens critique dans l’interpretation de ces resultats. [less ▲] Detailed reference viewed: 19 (0 ULg)Estimating Glomerular Filtration Rate in 2012 - Does the New Chronic Kidney Disease Epidemiology Equation Fare Better than Older Equations?DELANAYE, Pierre ; Krzesinski, Jean-Marie in European Nephrology (2012), 6(1), 15-20 Measuring or estimating glomerular filtration rate (GFR) is still considered the best way to apprehend global renal function. In 2009, the Chronic Kidney Disease Epidemiology (CKD-EPI) equation was ... [more ▼] Measuring or estimating glomerular filtration rate (GFR) is still considered the best way to apprehend global renal function. In 2009, the Chronic Kidney Disease Epidemiology (CKD-EPI) equation was proposed as a better estimator of GFR than the Modification of Diet in Renal Disease (MDRD) study equation. It is supposed to underestimate GFR to a lesser degree in higher GFR levels. In this article, we present and discuss the performances of this new equation. Based on articles published between 2009 and 2012, we underline its advantages, notably better knowledge of chronic kidney disease prevalence, but also its limitations, especially in some specific populations. Our conclusion is that all equations are estimations and that nephrologists should always remain cautions in their interpretation. [less ▲] Detailed reference viewed: 14 (2 ULg)Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) valuesCAVALIER, Etienne ; DELANAYE, Pierre ; VRANKEN, Laura et alin Nephrology Dialysis Transplantation (2012), 27 Background. The recommended target range for serum parathyroid hormone (PTH) in dialysis patients has changed from 150 to 300 pg/mL in the KDOQI guidelines to two to nine times the upper normal limit in ... [more ▼] Background. The recommended target range for serum parathyroid hormone (PTH) in dialysis patients has changed from 150 to 300 pg/mL in the KDOQI guidelines to two to nine times the upper normal limit in the KDIGO ones. Although inclusion/exclusion criteria for the reference population are highly important, they are usually not mentioned in the commercial kits. In this study, we used the same reference population of vitamin D-replete normal subjects to establish reference values for 10 commercial PTH kits. We evaluated whether this may improve the classification of dialysis patients according to the KDIGO compared to the use of reference values proposed by the manufacturers. Methods. We measured serum PTH with 10 different kits in 149 haemodialysis patients, and 240 25-OH-vitamin D-replete (>75 nmol/L) individuals with an estimated glomerular filtration rate >60 mL/min/1.73 m2. Results. For the 10 kits, our upper normal limit was lower than those of the manufacturers. The difference was, however, variable from one kit to another. The two kits that yielded the lowest and the highest absolute concentrations classified differently 84/149 patients (56.4%) according to the KDOQI and 53/149 (36.2%) according to the KDIGO using the manufacturers’ normal value.Using our normal values significantly decreased the discrepancies with 24/149 patients (16.1%) being still classified differently. Taking the measurement uncertainty into consideration, 8% of the patients only remained differently classified by these two kits. Conclusions. Using the same vitamin-D-replete population to establish the reference range for 10 commercial PTH kits significantly improved the classification of haemodialysis patients according to the KDIGO target range. [less ▲] Detailed reference viewed: 48 (5 ULg) Vascular calcifications in chronic kidney disease: can the Biologist be of some help?; ; et al in DELANAYE, Pierre (Ed.) Clinical Chemistry and Nephrology: the essential link (2012) Detailed reference viewed: 14 (2 ULg)Le débit de filtration glomérulaire est-il un déterminant de la concentration plasmatique du NGAL aux soins intensifs ?DELANAYE, Pierre ; ; et alPoster (2012) Detailed reference viewed: 14 (3 ULg)Vitamine D native chez le patient hémodialysé: efficacité et profil de sécurité. Une étude multicentrique, prospective et randomisée contre placebo sur un an.DELANAYE, Pierre ; WEEKERS, Laurent ; et alPoster (2012) Detailed reference viewed: 18 (3 ULg)How Measuring Glomerular Filtration Rate? Comparison of reference methodsDELANAYE, Pierre in Sahay, Manisha (Ed.) Basic Nephrology and Acute Kidney injury (2012) Detailed reference viewed: 13 (6 ULg)Assessment of kidney function: estimating GFR in children.DELANAYE, Pierre ; in Nature Reviews Nephrology (2012), 8(9), 503-504 Detailed reference viewed: 1 (0 ULg)Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?DELANAYE, Pierre ; DUBOIS, Bernard ; JOURET, François et alPoster (2012) Detailed reference viewed: 10 (0 ULg) |
||
